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ABSTRACT 
 Post-Traumatic Stress Disorder (PTSD) can develop after experiencing a very traumatic 
event which produces a profound and lasting aversive memory in the affected person. Annually, 
about 8 million people suffer from PTSD. Current treatments are not optimal in achieving a full 
extinction of the traumatic fear the patients reexperience. Therefore, how the brain processes and 
modulates fear memories continue to be an active area of research. The excitability of the 
infralimbic cortex (IL), a sub-region of the medial prefrontal cortex (mPFC), is important for fear 
extinction, but the effects of IL on fear conditioning have not been extensively studied. 
Pharmacogenetic approaches, such as Designer Receptors Exclusively Activated by Designer 
Drugs (DREADD), currently allow for specific and controlled manipulation of different areas of 
the brain to study their respective functions. The main purpose of this research is to determine 
whether the excitability of IL affects fear conditioning. We hypothesized that activation of IL 
during fear conditioning would decrease the acquired fear. To test this, adult male Sprague 
Dawley rats were surgically infused with a virus that expressed a stimulatory DREADD. Three 
weeks later, the rats were exposed to fear conditioning, and sacrificed for immunohistochemistry 
to examine neuronal activity. Preliminary results show that activation of the DREADD receptor 
increased labeling of c-Fos, and pErk, which indicates increased neuronal activity. This suggests 
that stimulating the DREADD receptors is activating that brain structure. Next, we will examine 
whether activation of IL during fear conditioning will decrease acquired fear levels. 
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